Grup de Recerca GEMMAIR (AGAUR)-Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), 43007 Tarragona, Spain.
Servei Medicina Interna, Hospital Universitari de Tarragona Joan XXIII, Mallafré Guasch, 4, 43007 Tarragona, Spain.
Int J Environ Res Public Health. 2022 Oct 18;19(20):13495. doi: 10.3390/ijerph192013495.
Nonalcoholic fatty liver disease (NAFLD) has emerged as the predominant cause of chronic liver injury; however, the mechanisms underlying its progression have not been fully elucidated. Pathophysiological studies have stated that NAFLD is significantly influenced by dietary and environmental factors that could participate in the development of NAFLD through different mechanisms. Currently, "plastic pollution" is one of the most challenging environmental problems worldwide since several plastics have potential toxic or endocrine disputing properties. Specifically, the intake of microplastics (MPs) and nanoplastics (NPs) in water or diet and/or the inhalation from suspended particles is well established, and these particles have been found in human samples. Laboratory animals exposed to MPs develop inflammation, immunological responses, endocrine disruptions, and alterations in lipid and energy metabolism, among other disorders. MPs additives also demonstrated adverse reactions. There is evidence that MPs and their additives are potential "obesogens" and could participate in NAFLD pathogenesis by modifying gut microbiota composition or even worsen liver fibrosis. Although human exposure to MPs seems clear, their relationship with NAFLD requires further study, since its prevention could be a possible personalized therapeutic strategy. Adequate mitigation strategies worldwide, reducing environmental pollution and human exposure levels of MPs, could reduce the risk of NAFLD.
非酒精性脂肪性肝病(NAFLD)已成为慢性肝损伤的主要原因;然而,其进展的机制尚未完全阐明。病理生理学研究表明,NAFLD 受饮食和环境因素的显著影响,这些因素可能通过不同的机制参与 NAFLD 的发生。目前,“塑料污染”是全球最具挑战性的环境问题之一,因为一些塑料具有潜在的毒性或内分泌干扰特性。具体来说,水中或饮食中摄入的微塑料(MPs)和纳米塑料(NPs),以及从悬浮颗粒中吸入,已经得到证实,并且这些颗粒已经在人类样本中发现。暴露于 MPs 的实验动物会出现炎症、免疫反应、内分泌紊乱以及脂质和能量代谢改变等疾病。 MPs 添加剂也表现出不良反应。有证据表明 MPs 及其添加剂是潜在的“致肥胖物”,通过改变肠道微生物群组成,甚至加重肝纤维化,可能参与 NAFLD 的发病机制。尽管人类接触 MPs 的情况似乎很清楚,但它们与 NAFLD 的关系仍需要进一步研究,因为预防可能是一种可能的个体化治疗策略。全球采取适当的缓解策略,减少环境污染和人类接触 MPs 的水平,可以降低 NAFLD 的风险。